Literature DB >> 21659744

Roger C. Bone, MD and the evolving paradigms of sepsis.

Robert Balk1.   

Abstract

Severe sepsis and septic shock are frequent causes of ICU admission, commonly encountered complications during the course of hospitalization, and among the most common causes of death in the noncoronary ICU. Dr. Roger C. Bone was a pioneer in our struggles to improve the early recognition and management of severe sepsis and septic shock. Through his leadership and guidance, great strides were made to develop a uniform definition and to ensure the comparability of clinical research trials to evaluate new therapeutic strategies and antimediator agents. Dr. Bone also helped shape our understanding of the various stages or physiologic alterations that occur in the septic patient which also drove forward the development of new therapeutic strategies. This chapter briefly reviews the impact Roger Bone has had on our current understanding and approach to the septic patient.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21659744     DOI: 10.1159/000323970

Source DB:  PubMed          Journal:  Contrib Microbiol        ISSN: 1420-9519


  4 in total

Review 1.  Neonatal sepsis and inflammatory mediators.

Authors:  Juliana Reis Machado; Danilo Figueiredo Soave; Marcos Vinícius da Silva; Liliana Borges de Menezes; Renata Margarida Etchebehere; Maria Luiza Gonçalves dos Reis Monteiro; Marlene Antônia dos Reis; Rosana Rosa Miranda Corrêa; Mara Rúbia Nunes Celes
Journal:  Mediators Inflamm       Date:  2014-12-30       Impact factor: 4.711

2.  Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients.

Authors:  Asmaa Nasr El-Din; Abdelhady Ragab Abdel-Gawad; Wesam Abdelgalil; Nahed F Fahmy
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

Review 3.  Biomarkers of sepsis.

Authors:  James D Faix
Journal:  Crit Rev Clin Lab Sci       Date:  2013 Jan-Feb       Impact factor: 6.250

Review 4.  Biomarkers for sepsis.

Authors:  Cesar Henriquez-Camacho; Juan Losa
Journal:  Biomed Res Int       Date:  2014-03-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.